InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: asmarterwookie post# 121488

Wednesday, 05/08/2013 10:59:43 AM

Wednesday, May 08, 2013 10:59:43 AM

Post# of 345970
Wook....I like that idea of buy one and get one free! I will look into my crystal ball and I just so happen to see this "buy one and get one free" in Peregrines future...a stock split! : )

A 2 for 1..... I believe is coming within 12-18 months. Unfortunately...the pros will not tell you that because 150M shares "will not" be enough ....once we get up to 300M shares outstanding "AND" a few quartere of Bavi sales incoming.....then 300M shares will not be enough.

Now 600M shares may hold us over for a few years....but guess what? Once mutual funds and stock indexes...etc....etc....all want The Bavi Edge in their portfolio for the long term....600M shares will not be enough.

When that time comes....it will be quite interesting that a group of night nurses could foresee this coming.

My immediate near term prediction.....is another analyst should initiating coverage as Piper Jaffray...most recently did....seems most logical to me..!..many of them just follow other analysts....and I think they had enough time for their DD after they see Charles Duncan arriving on scene. The funny thing is they may have even browsed this message board as well.....so when do they reveal themselves?? : )

Unless they want to play it conservative and wait till after ASCO.... but what kind of analyst cant analyze whats about to happen?? Unlike Peregrine who was forced to play it "conservative"....an analyst shouldnt be afraid to speak their mind and start coverage on Peregrine now.

GLTA!




"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News